SHE:300573 Revenue

Shenyang Xingqi Pharmaceutical had revenue of 740.99M CNY in the quarter ending September 30, 2025, with 35.34% growth. This brings the company's revenue in the last twelve months to 2.41B, up 33.62% year-over-year. In the year 2024, Shenyang Xingqi Pharmaceutical had annual revenue of 1.94B with 32.42% growth.

Revenue (ttm)

2.41B

Revenue Growth

+33.62%

P/S Ratio

6.95

Revenue / Employee

992.51K

Employees

2,426

Market Cap

16.74B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.94B	475.82M	32.42%
Dec 31, 2023	1.47B	217.71M	17.42%
Jan 1, 2023	1.25B	221.94M	21.59%
Jan 1, 2022	1.03B	339.23M	49.26%
Dec 31, 2020	688.68M	146.25M	26.96%
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2017	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2016	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2015	Upgrade Pro	Upgrade Pro	Upgrade Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Winner Medical	10.80B
Intco Medical Technology	9.85B
Tofflon Science and Technology Group	5.22B
Zhende Medical	4.32B
Micro-Tech (Nanjing) Co.,Ltd	3.12B
iRay Group	2.30B
Autek China	1.82B
Sansure Biotech	1.67B

Revenue Rankings